annual EBITDA:
$9.14B-$8.04B(-46.79%)Summary
- As of today (April 18, 2025), ABBV annual EBITDA is $9.14 billion, with the most recent change of -$8.04 billion (-46.79%) on December 1, 2024.
- During the last 3 years, ABBV annual EBITDA has fallen by -$14.80 billion (-61.82%).
- ABBV annual EBITDA is now -62.20% below its all-time high of $24.17 billion, reached on December 31, 2022.
Performance
ABBV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$1.49B-$6.37B(-130.51%)Summary
- As of today (April 18, 2025), ABBV quarterly EBITDA is -$1.49 billion, with the most recent change of -$6.37 billion (-130.51%) on December 1, 2024.
- Over the past year, ABBV quarterly EBITDA has stayed the same.
- ABBV quarterly EBITDA is now -119.79% below its all-time high of $7.53 billion, reached on March 31, 2022.
Performance
ABBV quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$12.88B-$5.34B(-29.31%)Summary
- As of today (April 18, 2025), ABBV TTM EBITDA is $12.88 billion, with the most recent change of -$5.34 billion (-29.31%) on December 1, 2024.
- Over the past year, ABBV TTM EBITDA has stayed the same.
- ABBV TTM EBITDA is now -49.10% below its all-time high of $25.32 billion, reached on September 30, 2022.
Performance
ABBV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ABBV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.8% | 0.0% | 0.0% |
| 3 y3 years | -61.8% | -139.3% | -47.5% |
| 5 y5 years | -25.3% | -136.0% | +4.6% |
ABBV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -62.2% | at low | -119.8% | at low | -49.1% | at low |
| 5 y | 5-year | -62.2% | at low | -119.8% | at low | -49.1% | +4.6% |
| alltime | all time | -62.2% | +154.9% | -119.8% | +3.9% | -49.1% | +940.0% |
AbbVie EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $9.14B(-46.8%) | -$1.49B(-130.5%) | $12.88B(-29.3%) |
| Sep 2024 | - | $4.88B(-2.4%) | $18.23B(+0.8%) |
| Jun 2024 | - | $5.00B(+11.5%) | $18.09B(-2.3%) |
| Mar 2024 | - | $4.49B(+16.5%) | $18.51B(+7.8%) |
| Dec 2023 | $17.17B(-29.0%) | $3.85B(-18.8%) | $17.17B(-9.7%) |
| Sep 2023 | - | $4.74B(-12.5%) | $19.01B(-11.3%) |
| Jun 2023 | - | $5.42B(+71.9%) | $21.43B(+8.2%) |
| Mar 2023 | - | $3.15B(-44.5%) | $19.80B(-18.1%) |
| Dec 2022 | $24.17B(+1.0%) | $5.69B(-20.6%) | $24.17B(-4.5%) |
| Sep 2022 | - | $7.17B(+89.0%) | $25.32B(+3.1%) |
| Jun 2022 | - | $3.79B(-49.7%) | $24.56B(-0.8%) |
| Mar 2022 | - | $7.53B(+10.2%) | $24.75B(+3.4%) |
| Dec 2021 | $23.93B(+94.2%) | $6.83B(+6.5%) | $23.93B(+30.9%) |
| Sep 2021 | - | $6.41B(+61.2%) | $18.29B(+5.7%) |
| Jun 2021 | - | $3.98B(-40.8%) | $17.30B(+16.8%) |
| Mar 2021 | - | $6.71B(+465.6%) | $14.82B(+20.2%) |
| Dec 2020 | $12.32B(+0.8%) | $1.19B(-78.1%) | $12.32B(-19.3%) |
| Sep 2020 | - | $5.42B(+262.9%) | $15.28B(+19.0%) |
| Jun 2020 | - | $1.49B(-64.6%) | $12.84B(-1.3%) |
| Mar 2020 | - | $4.22B(+1.9%) | $13.01B(+6.4%) |
| Dec 2019 | $12.23B(+47.1%) | $4.14B(+38.8%) | $12.23B(+87.1%) |
| Sep 2019 | - | $2.98B(+79.0%) | $6.53B(-7.8%) |
| Jun 2019 | - | $1.67B(-51.5%) | $7.08B(-13.5%) |
| Mar 2019 | - | $3.43B(-321.4%) | $8.19B(-1.4%) |
| Dec 2018 | $8.31B(-19.9%) | -$1.55B(-143.9%) | $8.31B(-29.1%) |
| Sep 2018 | - | $3.54B(+27.4%) | $11.72B(+7.0%) |
| Jun 2018 | - | $2.77B(-21.9%) | $10.95B(-2.2%) |
| Mar 2018 | - | $3.55B(+90.8%) | $11.20B(+7.9%) |
| Dec 2017 | $10.38B | $1.86B(-32.7%) | $10.38B(-7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $2.77B(-8.3%) | $11.16B(+1.6%) |
| Jun 2017 | - | $3.02B(+10.4%) | $10.98B(+3.6%) |
| Mar 2017 | - | $2.73B(+3.4%) | $10.59B(+4.7%) |
| Dec 2016 | $10.12B(+23.4%) | $2.64B(+2.0%) | $10.12B(+2.5%) |
| Sep 2016 | - | $2.59B(-1.6%) | $9.87B(+5.4%) |
| Jun 2016 | - | $2.63B(+16.4%) | $9.36B(+6.7%) |
| Mar 2016 | - | $2.26B(-5.6%) | $8.77B(+7.0%) |
| Dec 2015 | $8.20B(+128.8%) | $2.39B(+15.0%) | $8.20B(+60.7%) |
| Sep 2015 | - | $2.08B(+2.0%) | $5.10B(+26.0%) |
| Jun 2015 | - | $2.04B(+21.0%) | $4.05B(+8.9%) |
| Mar 2015 | - | $1.69B(-339.1%) | $3.72B(+3.7%) |
| Dec 2014 | $3.58B(-45.1%) | -$705.00M(-168.6%) | $3.58B(-40.3%) |
| Sep 2014 | - | $1.03B(-39.9%) | $6.00B(-8.6%) |
| Jun 2014 | - | $1.71B(+9.8%) | $6.57B(+0.4%) |
| Mar 2014 | - | $1.55B(-9.2%) | $6.55B(+0.3%) |
| Dec 2013 | $6.53B(-6.5%) | $1.71B(+7.4%) | $6.53B(-5.8%) |
| Sep 2013 | - | $1.59B(-5.2%) | $6.93B(-3.4%) |
| Jun 2013 | - | $1.68B(+9.4%) | $7.18B(-0.2%) |
| Mar 2013 | - | $1.54B(-27.3%) | $7.19B(+3.1%) |
| Dec 2012 | $6.98B(+41.3%) | $2.12B(+14.9%) | $6.98B(+10.1%) |
| Sep 2012 | - | $1.84B(+8.5%) | $6.34B(+30.2%) |
| Jun 2012 | - | $1.70B(+28.1%) | $4.87B(-3.1%) |
| Mar 2012 | - | $1.32B(-10.4%) | $5.03B(+1.7%) |
| Dec 2011 | $4.94B(-17.9%) | $1.48B(+300.8%) | $4.94B(+42.7%) |
| Sep 2011 | - | $368.85M(-80.1%) | $3.46B(+11.9%) |
| Jun 2011 | - | $1.85B(+49.6%) | $3.09B(+149.6%) |
| Mar 2011 | - | $1.24B | $1.24B |
| Dec 2010 | $6.02B(+3.8%) | - | - |
| Dec 2009 | $5.80B | - | - |
FAQ
- What is AbbVie annual EBITDA?
- What is the all time high annual EBITDA for AbbVie?
- What is AbbVie annual EBITDA year-on-year change?
- What is AbbVie quarterly EBITDA?
- What is the all time high quarterly EBITDA for AbbVie?
- What is AbbVie quarterly EBITDA year-on-year change?
- What is AbbVie TTM EBITDA?
- What is the all time high TTM EBITDA for AbbVie?
- What is AbbVie TTM EBITDA year-on-year change?
What is AbbVie annual EBITDA?
The current annual EBITDA of ABBV is $9.14B
What is the all time high annual EBITDA for AbbVie?
AbbVie all-time high annual EBITDA is $24.17B
What is AbbVie annual EBITDA year-on-year change?
Over the past year, ABBV annual EBITDA has changed by -$8.04B (-46.79%)
What is AbbVie quarterly EBITDA?
The current quarterly EBITDA of ABBV is -$1.49B
What is the all time high quarterly EBITDA for AbbVie?
AbbVie all-time high quarterly EBITDA is $7.53B
What is AbbVie quarterly EBITDA year-on-year change?
Over the past year, ABBV quarterly EBITDA has changed by $0.00 (0.00%)
What is AbbVie TTM EBITDA?
The current TTM EBITDA of ABBV is $12.88B
What is the all time high TTM EBITDA for AbbVie?
AbbVie all-time high TTM EBITDA is $25.32B
What is AbbVie TTM EBITDA year-on-year change?
Over the past year, ABBV TTM EBITDA has changed by $0.00 (0.00%)